BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9674698)

  • 21. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53.
    Pruschy M; Wirbelauer C; Glanzmann C; Bodis S; Krek W
    Cell Growth Differ; 1999 Mar; 10(3):141-6. PubMed ID: 10099827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC; Hickman ES; Lazzerini Denchi E; Caprara G; Colli E; Cecconi F; Müller H; Helin K
    Nat Cell Biol; 2001 Jun; 3(6):552-8. PubMed ID: 11389439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress signals induce transcriptionally inactive E2F-1 independently of p53 and Rb.
    O'Connor DJ; Lu X
    Oncogene; 2000 May; 19(20):2369-76. PubMed ID: 10828878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
    Maehara K; Yamakoshi K; Ohtani N; Kubo Y; Takahashi A; Arase S; Jones N; Hara E
    J Cell Biol; 2005 Feb; 168(4):553-60. PubMed ID: 15716376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S; Allen KE; Mason SL; La Thangue NB
    EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase-dependent apoptosis by ectopic expression of E2F-4.
    Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
    Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
    Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transcription factor E2F-1 in SV40 T antigen-induced cerebellar Purkinje cell degeneration.
    Athanasiou MC; Yunis W; Coleman N; Ehlenfeldt R; Clark HB; Orr HT; Feddersen RM
    Mol Cell Neurosci; 1998 Sep; 12(1-2):16-28. PubMed ID: 9770337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA.
    Yang XH; Sladek TL
    Biochem Biophys Res Commun; 1997 Mar; 232(2):336-9. PubMed ID: 9125176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the E2F-1/DP-1 transcription factor in murine development.
    Tevosian SG; Paulson KE; Bronson R; Yee AS
    Cell Growth Differ; 1996 Jan; 7(1):43-52. PubMed ID: 8788032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN; Pant V
    DNA Cell Biol; 1999 Dec; 18(12):911-22. PubMed ID: 10619603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor.
    Bandara LR; Girling R; La Thangue NB
    Nat Biotechnol; 1997 Sep; 15(9):896-901. PubMed ID: 9306407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interaction between DP-1 and p53.
    Sørensen TS; Girling R; Lee CW; Gannon J; Bandara LR; La Thangue NB
    Mol Cell Biol; 1996 Oct; 16(10):5888-95. PubMed ID: 8816502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.